<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To study the in vitro <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of polymorphonuclear leucocytes (PMNLs) to endothelial cells in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (BD), and the humoral and cellular factors which may contribute to <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 118 patients with BD and 60 healthy controls were studied </plain></SENT>
<SENT sid="2" pm="."><plain>In vitro <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of <z:chebi fb="0" ids="50076">chromium-51</z:chebi> labelled <z:mpath ids='MPATH_458'>normal</z:mpath> neutrophils to human umbilical vascular endothelial cell (HUVEC) monolayers were studied in the presence of <z:mpath ids='MPATH_458'>normal</z:mpath> serum or serum obtained from patients with BD </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Adhesion</z:e> of neutrophils from patients with BD to HUVEC stimulated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF), interleukin-1 (IL-1), and <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS) and <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (CD11a, CD11b, CD18 and L-selectin) expression on the patient's neutrophils and lymphocytes were determined, and the serum concentration of IL-8 was measured </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Sera from patients with BD were found to enhance the adherence of <z:mpath ids='MPATH_458'>normal</z:mpath> PMNLs to HUVEC monolayers in vitro </plain></SENT>
<SENT sid="5" pm="."><plain>Patients' sera induced an increase in surface expression of CD11a and CD18 on <z:mpath ids='MPATH_458'>normal</z:mpath> neutrophils and intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (ICAM-1) expression on HUVECs </plain></SENT>
<SENT sid="6" pm="."><plain>The number of CD11a positive neutrophils was greater in the blood of patients with BD than in that of healthy controls (89.4% v 71%; p &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Pretreatment of HUVECs with IL-1 alpha, TNF alpha or LPS resulted in an increased <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of patients' PMNLs greater than that observed for <z:mpath ids='MPATH_458'>normal</z:mpath> PMNLs </plain></SENT>
<SENT sid="8" pm="."><plain>Monoclonal antibodies to CD11a, CD11b, CD18, and ICAM-1 caused varying degrees of inhibition of neutrophil <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The concentration of IL-8 was also found to be significantly increased in sera of patients with BD (490 (SD 470) pg/ml) compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls (97.5 (56.3) pg/ml) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0001874'>Abnormalities of neutrophils</z:hpo>, endothelial cells, or both, have been suggested to be responsible for many of the clinical manifestations of BD </plain></SENT>
<SENT sid="11" pm="."><plain>Our findings may explain the underlying mechanism of neutrophil accumulation in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's lesions </plain></SENT>
</text></document>